Select a year:

4Moving Biotech completes the recruitment of its Phase I clinical trial in patients with knee osteoarthritis

Our subsidiary, 4Moving Biotech, dedicated to facing the global challenge of knee osteoarthritis, announces that it has reached a significant milestone by completing patient recruitment for its LASARE Phase I clinical trial. The Phase I trial is designed as a multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of intra-articular injection&hellip

Read More

4Moving Biotech at OARSI 2023

Our subsidiary 4Moving Biotech, was presented at OARSI- World Congress on Osteoarthritis. It was an excellent opportunity to share our subsidiary’s latest progress and development. Our subsidiary Co-founder/CMO Pr. Francis Berenbaum showcased two posters during the OARSI congress. First poster at OA clinical trial symposium on March 16, 2023 Poster title: GLP1 analogues as a&hellip

Read More

4Moving Biotech is attending at Gordon Research Conference

We are delighted to announce that Pr. Francis Berenbaum, Co-founder and CEO/CMO of our subsidiary 4Moving Biotech, is attending from March 19th-24th,2023, at Gordon Research Conference in Luca, Bragia, Italia as an invitedspeaker. His poster title is Glucagon-like Peptide-1 Analogues: Metabolic Roles and Beyond

Read More

Discover 4P-Pharma’s clinical vision

4P-Pharma is thrilled to share the last video of company portrait galleries realized in collaboration with the magazine Entreprendre to highlight our innovative company activities and story. This video focuses on our clinical vision, aiming to rapidly deliver effective, regenerated, first-in-class therapies for untreated serious diseases with high unmet medical needs. 4P-Pharma has developed a&hellip

Read More

4P-Pharma presents 4P-004 data at the ACR/ARP Annual Meeting in Atlanta

A poster on 4P-004 entitled “Protective Effects of Intra-Articular Formulated Liraglutide in Osteoarthritis: Preclinical Studies” (#1973) will be presented during the ACR/ARP Annual Meeting in Atlanta, Georgia November 8 – 13, 2019, by Pr. Francis Berenbaum (Professor of Rheumatology at Sorbonne University, in Paris (France)). For further information, please click on the following link:  

Read More